COMP <GO>
IT vs PG // EV/EBITDA & P/E VALUATION
Gartner Inc. (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: IT 8
— PG 6
▲ EV/EBITDA & P/E VALUATION LEADER: IT
LAST: $235.26 (+2.83%) • MKT CAP: $14.45B
valuation
12.1x
LAST: $163.56 (+1.23%) • MKT CAP: $374.48B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IT VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IT | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.80% | 51.20% | +17.60 | IT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 51.50% | 25.40% | +26.10 | IT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.1x | 16.2x | -4.10 | IT | /valuation <GO> |
| Free Cash Flow Yield | 7.02% | 3.77% | +3.25 | IT | /fcf-yield <GO> |
| Operating Margin | 15.80% | 24.30% | -8.50 | PG | /operating-margins <GO> |
| Net Profit Margin | 11.20% | 19.00% | -7.80 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | 0.30% | +3.40 | IT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.48 | 5.59 | -2.11 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.8 | 62.0 | +2.80 | IT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 0.87 | +0.18 | IT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.1x | 21.7x | -3.60 | IT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.45B | $374.48B | -$360.04B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IT REV | PG REV | IT GROSS % | PG GROSS % | IT FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.50B | $84.28B | 68.8% | 51.2% | $998.0M | $14.04B |
| FY 2024 | $6.27B | $84.04B | 68.3% | 51.4% | $1.20B | $16.52B |
| FY 2023 | $5.91B | $82.01B | — | — | $889.9M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IT // BETA 1.05
PG // BETA 0.87